Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency

被引:35
作者
Mangione, R [1 ]
Guyon, F [1 ]
Taine, L [1 ]
Wen, ZQ [1 ]
Roux, D [1 ]
Vergnaud, A [1 ]
Maugey-Laulom, B [1 ]
Horovitz, J [1 ]
Saura, R [1 ]
机构
[1] Hop Pellegrin, Ctr Diagnost, F-33076 Bordeaux, France
关键词
fetal karyotype; nuchal translucency; chromosomal abnormalities; fetal abnormalities; genetic syndromes; fetal outcome;
D O I
10.1159/000053941
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: One of the concerns of prenatal diagnosis is to find sensitive markers to screen for chromosome abnormalities, such as serum assays or nuchal translucency (NT). This study reports our experience with NT measurement during the first trimester of pregnancy. Materials: The study was performed prospectively on 252 fetuses with either NT greater than or equal to3 mm or cystic hygroma. Results: We observed 50 abnormal karyotypes, i.e. 19.8%. The incidence of chromosome abnormalities increased with increasing maternal age and increasing NT thickness. For the 202 fetuses with normal karyotypes, outcome was unfavourable in 32 cases: 23 elective terminations of pregnancy, 8 spontaneous abortions and I neonatal death. Outcome was favourable in 141 cases. Twenty-nine pregnancies were lost to follow-up. Conclusion: Measurement of NT at 12 weeks' gestation seems to be a good marker for chromosome abnormalities. When the karyotype is normal, the pregnancy outcome remains correlated with the degree of NT thickness. The finding of NT >3 mm between 10 and 14 weeks' gestation dictates rigorous ultrasound monitoring and caution when predicting pregnancy outcome. Copyrlight (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:360 / 363
页数:4
相关论文
共 34 条
  • [1] Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening - A prospective study
    Benattar, C
    Audibert, F
    Taieb, J
    Ville, Y
    Roberto, A
    Lindenbaum, A
    Frydman, R
    [J]. FETAL DIAGNOSIS AND THERAPY, 1999, 14 (02) : 112 - 117
  • [2] First trimester screening for Down's syndrome using maternal serum PAPP-A and free β-hCG in combination with fetal nuchal translucency thickness
    Biagiotti, R
    Brizzi, L
    Periti, E
    d'Agata, A
    Vanzi, E
    Cariati, E
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (08): : 917 - 920
  • [3] Outcome of fetuses with enlarged nuchal translucency and normal karyotype
    Bilardo, CM
    Pajkrt, E
    de Graaf, I
    Mol, BW
    Bleker, OP
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 11 (06) : 401 - 406
  • [4] Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation
    Brady, AF
    Pandya, PP
    Yuksel, B
    Greenough, A
    Patton, MA
    Nicolaides, KH
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) : 222 - 224
  • [5] TRANSVAGINAL SONOGRAPHY - DETECTION OF FINDINGS SUGGESTIVE OF FETAL CHROMOSOMAL-ANOMALIES IN THE 1ST AND EARLY 2ND TRIMESTERS
    BRONSHTEIN, M
    BLUMENFELD, Z
    [J]. PRENATAL DIAGNOSIS, 1992, 12 (07) : 587 - 593
  • [6] Brun J.-L., 1995, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V24, P162
  • [7] FIRST TRIMESTER DIAGNOSIS OF FETAL NUCHAL EDEMA - REPORT OF 29 CASES
    BRUN, JL
    SAURA, R
    HOROVITZ, J
    MAUGEY, B
    TAINE, L
    ROUX, D
    VERGNAUD, A
    [J]. FETAL DIAGNOSIS AND THERAPY, 1994, 9 (04) : 246 - 251
  • [8] Chaban FK, 1996, PRENATAL DIAG, V16, P537, DOI 10.1002/(SICI)1097-0223(199606)16:6<537::AID-PD911>3.0.CO
  • [9] 2-4
  • [10] Charasson T., 1997, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V26, P671